You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動|復宏漢霖續漲9%,錄得6連漲,2025全球研發日重磅舉行
格隆匯 04-17 13:47

復宏漢霖(2696.HK)繼續大漲9%,錄得6連漲走出反轉行情,且有望再度刷新階段新高,現報34.9港元,總市值190億港元。消息上,復宏漢霖近日舉行2025全球研發日。公司在會上表示,2024年業績期內,公司在全球範圍內完成25項上市註冊申請遞交,並獲得17項批準。截至目前,復宏漢霖已有6款產品在中國獲批上市,4款產品在國際獲批上市,觸達50多個國家和地區。未來四年,復宏漢霖計劃在美國再推動8款生物藥上市,覆蓋帕妥珠單抗、地舒單抗等多個產品。儘管有關稅風波的幹擾,但券商分析師指出,這並不意味着美國市場就不能做了,恰恰相反,企業更需要因此而加速出海。就復宏漢霖而言,目前除了在歐洲、美國、澳洲等地已經完成海外團隊的建設以外,公司並且把全球第三大製藥市場日本,作爲出海的下一個重點目標,正大力推進在日本市場自建註冊和臨牀開發團隊。(格隆匯)

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account